Abstract
OBJECTIVES: To develop a robust algorithm to accurately calculate 'daily complete dose counts' for inhaled medicines, used in percent adherence calculations, from electronically-captured nebulizer data within the CFHealthHub Learning Health System.
METHODS: A multi-center, cross-sectional study involved participants and clinicians reviewing real-world inhaled medicine usage records and triangulating them with objective nebulizer data to establish a consensus on 'daily complete dose counts.' An algorithm, which used only objective nebulizer data, was then developed using a derivation dataset and evaluated using internal validation dataset. The agreement and accuracy between the algorithm-derived and consensus-derived 'daily complete dose counts' was examined, with the consensus-derived count as the reference standard.
RESULTS: Twelve people with CF participated. The algorithm derived a 'daily complete dose count' by screening out 'invalid' doses (those <60s in duration or run in cleaning mode), combining all doses starting within 120s of each other, and then screening out all doses with duration < 480s which were interrupted by power supply failure. The kappa co-efficient was 0.85 (0.71-0.91) in the derivation and 0.86 (0.77-0.94) in the validation dataset.
CONCLUSIONS: The algorithm demonstrated strong agreement with the participant-clinician consensus, enhancing confidence in CFHealthHub data. Publishingdata processing methods can encourage trust in digital endpoints and serve as an exemplar for other projects.
Original language | English |
---|---|
Pages (from-to) | 759-771 |
Number of pages | 13 |
Journal | Expert Review of Pharmacoeconomics and Outcomes Research |
Volume | 24 |
Issue number | 6 |
DOIs | |
Publication status | Published - Jul 2024 |
Keywords
- Humans
- Cystic Fibrosis/drug therapy
- Administration, Inhalation
- Cross-Sectional Studies
- Adult
- Algorithms
- Nebulizers and Vaporizers
- Male
- Female
- Medication Adherence
- Young Adult
- Middle Aged